MX9505065A - Composicion farmaceutica, aplicable oralmente. - Google Patents
Composicion farmaceutica, aplicable oralmente.Info
- Publication number
- MX9505065A MX9505065A MX9505065A MX9505065A MX9505065A MX 9505065 A MX9505065 A MX 9505065A MX 9505065 A MX9505065 A MX 9505065A MX 9505065 A MX9505065 A MX 9505065A MX 9505065 A MX9505065 A MX 9505065A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- pharmaceutical composition
- amino acid
- water
- used pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe una composicion farmacéutica, oralmente aplicable, por la que la composicion solida contiene por lo menos un ingrediente activo, por lo menos un desintegrante, así como también por lo menos un ingrediente adicional farmacéutico, usual. Además, la composicion contiene por lo menos un ingrediente que acelera la descomposicion de la composicion en la boca o en un líquido, por lo que el ingrediente es un aminoácido soluble en agua, un derivado de aminoácido soluble en agua y/o una sal de aminoácido soluble en agua.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4444051A DE4444051A1 (de) | 1994-12-10 | 1994-12-10 | Pharmazeutische, oral anwendbare Zubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9505065A true MX9505065A (es) | 1997-01-31 |
Family
ID=6535486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9505065A MX9505065A (es) | 1994-12-10 | 1995-12-05 | Composicion farmaceutica, aplicable oralmente. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6008249A (es) |
EP (1) | EP0715857A3 (es) |
JP (1) | JPH08208520A (es) |
KR (1) | KR100408582B1 (es) |
AU (1) | AU697187B2 (es) |
CA (1) | CA2164777A1 (es) |
DE (1) | DE4444051A1 (es) |
MX (1) | MX9505065A (es) |
TW (1) | TW449483B (es) |
ZA (1) | ZA9510427B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3860797A (en) * | 1997-07-16 | 1999-02-10 | Antrin Research Limited | Pharmaceutical formulations for oral administration |
TW527195B (en) | 1997-10-09 | 2003-04-11 | Ssp Co Ltd | Fast-soluble solid pharmaceutical combinations |
US6217878B1 (en) * | 1999-08-13 | 2001-04-17 | Amway Corporation | Method of preparing echinacea powder |
US6277409B1 (en) | 2000-02-11 | 2001-08-21 | Mcneil-Ppc, Inc. | Protective coating for tablet |
JP2001278812A (ja) * | 2000-03-27 | 2001-10-10 | Kyoto Pharmaceutical Industries Ltd | 錠剤用崩壊剤及びこれを用いた錠剤 |
KR100523242B1 (ko) * | 2000-05-18 | 2005-10-24 | 한미약품 주식회사 | 이부프로펜을 함유하는 정제 조성물 |
JP4889846B2 (ja) * | 2000-06-20 | 2012-03-07 | キリンフードテック株式会社 | 高甘味度甘味料含有組成物 |
JP2002060339A (ja) * | 2000-08-17 | 2002-02-26 | Takeda Chem Ind Ltd | 高甘味度甘味料含有組成物およびその利用 |
US6660302B1 (en) | 2000-09-06 | 2003-12-09 | Chr. Hansen, Inc. | Dry-powder film coating composition and method of preparation |
SE0100200D0 (sv) * | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
WO2003084512A1 (en) * | 2001-10-03 | 2003-10-16 | Robert Gow | Oral delivery of a botanical |
US7291352B2 (en) | 2001-10-03 | 2007-11-06 | Herbalscience Llc | Methods and compositions for oral delivery of Areca and mate' or theobromine |
US20050053678A1 (en) * | 2001-10-03 | 2005-03-10 | Gow Robert T. | Methods and compositions for betel nut chewing gum |
US7037524B2 (en) * | 2001-10-03 | 2006-05-02 | Herbalscience, Llc | Oral delivery of a botanical |
US20050069596A1 (en) * | 2001-10-03 | 2005-03-31 | Gow Robert T. | Compositions and methods comprising kava and anti-anxiety compounds |
SI1355633T1 (en) * | 2001-12-19 | 2005-06-30 | Astrazeneca Ab | NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate |
KR20030055571A (ko) * | 2001-12-27 | 2003-07-04 | 주식회사 백텍 | 카르복실 메틸 세룰로오스를 이용한 서방성마이크로스피어 제제의 개발 |
JP2004123712A (ja) * | 2002-08-01 | 2004-04-22 | Rohto Pharmaceut Co Ltd | 医薬組成物 |
US20050037025A1 (en) * | 2002-10-03 | 2005-02-17 | Gow Robert T. | Methods and compositions comprising kava and mate' or theobromine |
US20070077297A1 (en) | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
EP2291182A1 (en) * | 2008-05-13 | 2011-03-09 | Genmedica Therapeutics SL | Salicylate conjugates useful for treating metabolic disorders |
US20100120776A1 (en) * | 2008-11-12 | 2010-05-13 | Hall Bioscience Corporation | Carbocysteine medical foods |
US20100239552A1 (en) * | 2009-03-16 | 2010-09-23 | Genmedica Therapeutics Sl | Combination Therapies for Treating Metabolic Disorders |
CN102427809B (zh) * | 2009-03-16 | 2014-10-01 | 根梅迪卡治疗公司 | 用于治疗代谢性疾病的抗炎剂和抗氧化剂轭合物 |
US8466197B2 (en) | 2010-12-14 | 2013-06-18 | Genmedica Therapeutics Sl | Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE534529A (es) * | 1954-01-28 | |||
US3845210A (en) * | 1968-05-09 | 1974-10-29 | Y Mito | Solid composition comprising indolylaliphatic acid derivatives for forming an injection |
JPS59104326A (ja) * | 1982-12-04 | 1984-06-16 | Toyo Jozo Co Ltd | マクロライド抗生物質の安定な経口用製剤および安定化法 |
JPS6013712A (ja) * | 1983-07-05 | 1985-01-24 | Rikagaku Kenkyusho | 抗アレルギ−薬剤 |
JPS60161925A (ja) * | 1984-02-02 | 1985-08-23 | Sanwa Kagaku Kenkyusho:Kk | 安定なカリジノゲナーゼ打錠製剤の製法 |
JPS6245523A (ja) * | 1985-08-23 | 1987-02-27 | Tanabe Seiyaku Co Ltd | 食欲抑制剤 |
JPS6281316A (ja) * | 1985-10-04 | 1987-04-14 | Tanabe Seiyaku Co Ltd | 血小板凝集抑制剤 |
JPS62205025A (ja) * | 1986-03-06 | 1987-09-09 | Zeria Shinyaku Kogyo Kk | 抗潰瘍剤 |
US5057317A (en) * | 1987-03-24 | 1991-10-15 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
US4866046A (en) * | 1988-05-31 | 1989-09-12 | Top Laboratories, Inc. | Low-dosage sublingual aspirin |
DE3922441A1 (de) * | 1989-07-07 | 1991-01-17 | Pharmatrans Sanaq Ag | Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung |
KR920008161B1 (ko) * | 1990-02-19 | 1992-09-24 | 한미약품공업주식회사 | 오메프라졸 경구용 약제의 제조방법 |
HU222489B1 (hu) * | 1990-07-25 | 2003-07-28 | Novartis Ag. | Stabilizált gyógyszerkészítmények és eljárás az előállításukra |
CA2128821A1 (en) * | 1993-07-27 | 1995-01-28 | Dilip J. Gole | Freeze-dried pharmaceutical dosage form and process for separation thereof |
DE4444052A1 (de) * | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
JP4683936B2 (ja) * | 2005-01-26 | 2011-05-18 | 三洋電機株式会社 | 空気調和装置 |
-
1994
- 1994-12-10 DE DE4444051A patent/DE4444051A1/de not_active Withdrawn
-
1995
- 1995-11-17 EP EP95118095A patent/EP0715857A3/de not_active Withdrawn
- 1995-11-20 AU AU37945/95A patent/AU697187B2/en not_active Expired
- 1995-11-21 TW TW084112363A patent/TW449483B/zh not_active IP Right Cessation
- 1995-11-30 JP JP7312613A patent/JPH08208520A/ja active Pending
- 1995-12-04 US US08/566,824 patent/US6008249A/en not_active Expired - Lifetime
- 1995-12-05 MX MX9505065A patent/MX9505065A/es unknown
- 1995-12-07 KR KR1019950047252A patent/KR100408582B1/ko not_active IP Right Cessation
- 1995-12-08 ZA ZA9510427A patent/ZA9510427B/xx unknown
- 1995-12-08 CA CA002164777A patent/CA2164777A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU697187B2 (en) | 1998-10-01 |
KR960021060A (ko) | 1996-07-18 |
US6008249A (en) | 1999-12-28 |
KR100408582B1 (ko) | 2004-03-04 |
DE4444051A1 (de) | 1996-06-13 |
TW449483B (en) | 2001-08-11 |
JPH08208520A (ja) | 1996-08-13 |
EP0715857A2 (de) | 1996-06-12 |
ZA9510427B (en) | 1996-06-18 |
CA2164777A1 (en) | 1996-06-11 |
EP0715857A3 (de) | 1997-05-28 |
AU3794595A (en) | 1996-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9505065A (es) | Composicion farmaceutica, aplicable oralmente. | |
MX9505064A (es) | Composicion farmaceutica, aplicable oralmente. | |
IL127244A (en) | Substituted amines, methods of their preparation and pharmaceutical compositions containing them | |
ATE260646T1 (de) | Schnell zerfallende orale dosierungsform | |
BG100946A (en) | New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them | |
NZ325060A (en) | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone | |
MX9706449A (es) | Composicion farmaceutica para compuestos de piperidinalcanol. | |
MX9504034A (es) | Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas. | |
HRP980163B1 (en) | Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates | |
CA2329005A1 (en) | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems | |
NZ506188A (en) | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof | |
BR9714358A (pt) | Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
BG105257A (en) | New oral formulation for 5-ht4 agonists or antagonists | |
CA2270177A1 (en) | Transdermal administration of ment | |
MY118828A (en) | Substituted amino compounds and their use as substances having an analgesic effect | |
PL320560A1 (en) | Pharmaceutic composition | |
GEP20063719B (en) | Prevention of Migraine Recurrence | |
MX9708394A (es) | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. | |
RU94040150A (ru) | Стабильная лиофилизированная композиция тиотепа, способ ее получения | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
PL329036A1 (en) | Inclusive compounds of diclophenac and cyclodextrin | |
MY122477A (en) | Sertraline oral concentrate | |
BG106151A (en) | Pharmaceutical complex | |
MY118175A (en) | Crystalline pharmaceutical product | |
CY2499B1 (en) | Use of nk-1 receptor antagonists for treating stress disorders. |